PTC Therapeutics (PTCT) PT Raised to $43 at Barclays
Tweet
Share
E-mail
Get Alerts PTCT Hot Sheet
Price: $70.09 -2.4%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Barclays raised its price target on PTC Therapeutics (NASDAQ: PTCT) to $43.00 (from $40.00) while maintaining a Equalweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PTC Therapeutics to Participate in Upcoming Investor Conferences
- Marvell (MRVL) PT Raised to $325 at Oppenheimer
- Sarana Menara Nusantara Tbk (TOWR:IJ) (SMNUF) PT Lowered to IDR640 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
